Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes

IntroductionA number of studies have demonstrated a key role of miRNA isolated from cells, tissue or body fluids as disease-specific biomarkers of autoimmune rheumatic diseases including rheumatoid arthritis (RA) and systemic sclerosis (SSc). Also, the expression level of miRNA is changing during di...

Full description

Bibliographic Details
Main Authors: Marzena Ciechomska, Leszek Roszkowski, Tomasz Burakowski, Magdalena Massalska, Anna Felis-Giemza, Adria-Jaume Roura
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
miRNA
baricitinib
monocytes
sequencing
synovial fluids
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.980247/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.980247/full

Similar Items